DeVal

N/A

Report date: 2025/03/18 20:00:05

NME

Base Information

Drug NameDeVal

Drug Alias NameN/A

ClassificationNatural product/ExtractSmall molecules

Mechanisms of ActionCalcineurin stimulantsPhosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN stimulants

TargetsCalcineurinPhosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN

Therapy Area/IndicationsColonic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesInnovus Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesInnovus Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsColonic Neoplasms

Other Information

ATC CodeN/A